Literature DB >> 1190853

Urinary copper excretion in rheumatoid arthritis.

W McMurray, V M Martin, P Scudder, J Stocks, A G White, T L Dormandy.   

Abstract

The pattern of urinary copper excretion in relation to urine osmolality (as shown by series of aliquots of urine) was studied in rheumatoid patients and in control groups. Rheumatoid patients showed an abnormal copper excretion pattern compared with nonrheumatoid subjects. This was not a direct function of the raised serum copper in rheumatoid disease. Measurements based on 24-hour series of aliquots of urine (as distinct from total pooled 24-hour collections) have been shown to be a useful and sensitive method for studying copper excretion patterns.

Entities:  

Mesh:

Substances:

Year:  1975        PMID: 1190853      PMCID: PMC1006424          DOI: 10.1136/ard.34.4.340

Source DB:  PubMed          Journal:  Ann Rheum Dis        ISSN: 0003-4967            Impact factor:   19.103


  13 in total

1.  INDOMETHACIN: A NEW ANTI-RHEUMATIC DRUG.

Authors:  N EGELIUS
Journal:  Acta Rheumatol Scand       Date:  1965

2.  [On the diagnosis of the activity of chronic rheumatic diseases, with special reference to the quantitative determination of haptoglobins and caeruloplasmin].

Authors:  W MULLER; R KLUTHE; H MULLER
Journal:  Z Rheumaforsch       Date:  1963-02

3.  Osmometry.

Authors:  T L Dormandy
Journal:  Lancet       Date:  1967-02-04       Impact factor: 79.321

4.  Plasma-zinc and copper in pregnancy and after oral contraceptives.

Authors:  J A Halsted; B M Hackley; J C Smith
Journal:  Lancet       Date:  1968-08-03       Impact factor: 79.321

5.  Renal abnormalities in rheumatoid arthritis.

Authors:  R J Bulger; L A Healey; P Polinsky
Journal:  Ann Rheum Dis       Date:  1968-07       Impact factor: 19.103

6.  The treatment of rheumatoid arthritis and necrotizing vasculitis with penicillamine.

Authors:  I A Jaffe
Journal:  Arthritis Rheum       Date:  1970 Jul-Aug

7.  Serum ceruloplasmin concentration in rheumatoid arthritis, ankylosing spondylitis, psoriasis and sarcoidosis.

Authors:  P Koskelo; M Kekki; M Virkkunen; A Lassus; T Somer
Journal:  Acta Rheumatol Scand       Date:  1966

8.  Reduced glomerular function in rheumatoid arthritis.

Authors:  H C Burry
Journal:  Ann Rheum Dis       Date:  1972-01       Impact factor: 19.103

9.  Penicillamine in rheumatoid disease: a long-term study.

Authors:  A T Day; J R Golding; P N Lee; A D Butterworth
Journal:  Br Med J       Date:  1974-02-02

10.  Treatment of rheumatoid arthritis with fenoprofen: comparison with aspirin.

Authors:  E C Huskisson; J A Wojtulewski; H Berry; J Scott; F D Hart; H W Balme
Journal:  Br Med J       Date:  1974-02-02
View more
  5 in total

1.  Serum copper and caeruloplasmin in ankylosing spondylitis, systemic sclerosis, and morphea.

Authors:  M I Jayson; P Davis; J T Whicher; G Walters
Journal:  Ann Rheum Dis       Date:  1975-10       Impact factor: 19.103

2.  Serum copper and its relationship to clinical symptoms in rheumatoid arthritis.

Authors:  D H Brown; W W Buchanan; A F el-Ghobarey; W E Smith; J Teape
Journal:  Ann Rheum Dis       Date:  1979-04       Impact factor: 19.103

3.  Serum copper and erythrocyte superoxide dismutase in rheumatoid arthritis.

Authors:  J C Banford; D H Brown; R A Hazelton; C J McNeil; R D Sturrock; W E Smith
Journal:  Ann Rheum Dis       Date:  1982-10       Impact factor: 19.103

4.  Serum copper and related variables in rheumatoid arthritis.

Authors:  P R Scudder; D Al-Timimi; W McMurray; A G White; B C Zoob; T L Dormandy
Journal:  Ann Rheum Dis       Date:  1978-02       Impact factor: 19.103

5.  Copper and inflammation.

Authors:  M W Whitehouse; W R Walker
Journal:  Agents Actions       Date:  1978-01
  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.